Pharmabiz

Bayer’s Hyrnuo gets US FDA accelerated approval to treat patients with previously treated advanced HER2-mutant NSCLC

Bayer’s Hyrnuo gets US FDA accelerated approval to treat patients with previously treated advanced HER2-mutant NSCLC: Berlin Friday, November 21, 2025, 11:00 Hrs [IST] Following ...
Pharmabiz

Chugai obtains approval for FoundationOne CDx Cancer Genomic Profile to be used as a companion diagnostic for repotrectinib with NTRK fusion-positive solid-tumours

Chugai obtains approval for FoundationOne CDx Cancer Genomic Profile to be used as a companion diagnostic for repotrectinib with NTRK fusion-positive solid-tumours: Tokyo Friday, ...
Pharmabiz

Alexion’s Koselugo approved in US for adults with neurofibromatosis type 1

Alexion’s Koselugo approved in US for adults with neurofibromatosis type 1: Cambridge, UK Friday, November 21, 2025, 09:00 Hrs [IST] Alexion, AstraZeneca Rare Disease’s Koselu ...
Pharmabiz

AIOCD asks traders to strictly comply with the ban on 35 FDCs

AIOCD asks traders to strictly comply with the ban on 35 FDCs: Peethaambaran Kunnathoor, Chennai Friday, November 21, 2025, ...
Pharmabiz

NCISM grants permission to 31 new Ayurveda Medical Colleges in AY 2025-26

NCISM grants permission to 31 new Ayurveda Medical Colleges in AY 2025-26: Gireesh Babu, New Delhi Friday, November 21, 2025, ...
Pharmabiz

GenAI propels data-driven clinical decision-making & personalized care delivery: Ganesh Nathella

GenAI propels data-driven clinical decision-making & personalized care delivery: Ganesh Nathella: Nandita Vijayasimha, Bengaluru Friday, November 21, 2025, 08:00 Hrs [IST] Healthc ...
Pharmabiz

Panel asks DoP to keep control over prices of stents and monitor overcharging

Panel asks DoP to keep control over prices of stents and monitor overcharging: Gireesh Babu, New Delhi Friday, November 21, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Chemic ...
Pharmabiz

NABL issues terms & conditions to testing labs for obtaining and maintaining NABL Accreditation

NABL issues terms & conditions to testing labs for obtaining and maintaining NABL Accreditation: Shardul Nautiyal, Mumbai Friday, November 21, 2025, 08:00 Hrs [IST] The National A ...
Pharmabiz

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
Pharmabiz

Medanta launches film to create awareness around prostate cancer

Medanta launches film to create awareness around prostate cancer: Our Bureau, Mumbai Thursday, November 20, 2025, 17:25 Hrs [IST] Medanta, one of India’s leading super-specialit ...
Pharmabiz

Actimed Therapeutics inks licensing agreement with Mankind Pharma

Actimed Therapeutics inks licensing agreement with Mankind Pharma: Our Bureau, Bengaluru Thursday, November 20, 2025, 17:15 Hrs [IST] Actimed Therapeutics, a UK based clinical sta ...
Pharmabiz

Tonix Pharma announces US commercial availability of Tonmya as a first-in-class fibromyalgia treatment

Tonix Pharma announces US commercial availability of Tonmya as a first-in-class fibromyalgia treatment: Chatham, New Jersey Thursday, November 20, 2025, 17:00 Hrs [IST] Tonix Phar ...